Louis C Bock's Net Worth
-$154 Thousand
Who is Louis C Bock?
Louis C Bock does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., SGX PHARMACEUTICALS, INC., Orexigen Therapeutics, Inc., ZOGENIX, INC., DYNAVAX TECHNOLOGIES CORP, HEAT BIOLOGICS, INC., ALIMERA SCIENCES INC, Somaxon Pharmaceuticals, Inc., and VAXGEN INC.
SEC CIK
Louis C Bock's CIK is 0001279735
Past Insider Trading and Trends
2014 was Louis C Bock's most active year for acquiring shares with 4 total transactions. Louis C Bock's most active month to acquire stocks was the month of May. 2022 was Louis C Bock's most active year for disposing of shares, totalling 4 transactions. Louis C Bock's most active month to dispose stocks was the month of February. 2005 saw Louis C Bock paying a total of $464,400.00 for 55,000 shares, this is the most they've acquired in one year. In 2008 Louis C Bock cashed out on 32,500 shares for a total of $16,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HORIZON PHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.2M |
$9.00 |
—
| 2.2M |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SGX PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.55M |
$3.00 | -$7,640,241.00 |
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
∞
| 2.05M |
—
|
—
| 2.05M |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Orexigen Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +4.90% | 1.32K |
$5.58 | $7,392.18 | 28.38K |
Nov 18
| |||
Form 4
|
∞
| 27.05K |
$5.57 | $150,544.38 | 27.05K |
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
| -9.04% | -300.00K |
$7.50 | -$2,250,000.00 | 3.02M |
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -0.00% | -100.00 |
$15.00 | -$1,500.00 | 2.72M |
Nov 21
| |||
Form 4
| -0.10% | -2.80K |
$15.02 | -$42,060.58 | 2.72M |
Nov 19 - Nov 20
| |||
Form 4
| -0.59% | -16.14K |
$15.53 | -$250,681.93 | 2.72M |
Nov 16
| |||
Form 4
| -1.10% | -30.42K |
$15.66 | -$476,484.64 | 2.74M |
Nov 16
| |||
Form 4
| -0.05% | -1.50K |
$15.58 | -$23,356.45 | 2.77M |
Nov 15
| |||
Form 4
| -0.51% | -14.21K |
$15.59 | -$221,417.50 | 2.77M |
Nov 15
| |||
Form 4
| -0.18% | -14.81K |
$15.86 | -$230,168.93 | 8.35M |
Nov 14 - Nov 15
| |||
Form 4
|
∞
| 2.8M |
—
|
—
| 2.8M |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZOGENIX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
$33.02 | -$718,734.93 | 654 |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
| +30.70% | 1.25M |
$2.00 | $2,500,000.00 | 5.32M |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
∞
| 4.07M |
$4.00 |
—
| 4.07M |
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $10.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
| +969.84% | 193.92K |
—
|
—
| 213.91K |
Feb 24
| |||
Form 4
|
∞
| 20K |
$7.50 | $149,962.50 | 20K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||